SCHEMBL803498

SCHEMBL803498

COC(=O)c1ccc2c(c1)CC[C@H]2NC(=O)CC(C)C

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KMT2A Q03164 4/20 0.47
MEN1 O00255 2/20 0.47
MAPT P10636 1/20 0.47
CHRNB2 P17787 1/20 0.45
CHRNA4 P43681 1/20 0.45
PDE4A P27815 1/20 0.43
PDE4B Q07343 1/20 0.43
PDE4C Q08493 1/20 0.43
PDE4D Q08499 1/20 0.43
CA12 O43570 3/20 0.42
CA7 P43166 3/20 0.42
CA14 Q9ULX7 3/20 0.42
CA1 P00915 2/20 0.41
CA2 P00918 2/20 0.41
CA9 Q16790 2/20 0.41
GAA P10253 1/20 0.41
HPGD P15428 1/20 0.41
TAS1R3 Q7RTX0 1/20 0.41
TAS1R1 Q7RTX1 1/20 0.41
L3MBTL1 Q9Y468 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL803556 0.91 KMT2A (0.47) KMT2AMEN1MAPTCHRNB2CHRNA4
SCHEMBL2820245 0.91 KMT2A (0.47) KMT2AMEN1MAPTCHRNB2CHRNA4
SCHEMBL785070 0.88 CA12 (0.43) KMT2APDE4APDE4BPDE4CPDE4D
SCHEMBL785709 0.88 CA12 (0.43) KMT2APDE4APDE4BPDE4CPDE4D
SCHEMBL803222 0.84 KMT2A (0.54) KMT2AMAPTHPGDL3MBTL1TAOK3
SCHEMBL24890725 0.82 KMT2A (0.52) KMT2AMEN1MAPTCHRNB2CHRNA4
SCHEMBL803234 0.81 KMT2A (0.45) KMT2AMEN1MAPTCHRNB2CHRNA4
SCHEMBL10210316 0.78 CHRNB2 (0.51) KMT2AMEN1MAPTCHRNB2CHRNA4
SCHEMBL15912315 0.78 ALDH1A1 (0.57) HPGDTAS1R3TAS1R1
SCHEMBL784523 0.78 PDE4A (0.42) KMT2APDE4APDE4BPDE4CPDE4D

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8680159-B2 Bradykinin 1 receptor modulating compounds GRUENENTHAL GMBH (DE) 2014-03-25 US disclosed
US-8680159-B2 Bradykinin 1 receptor modulating compounds GRUENENTHAL GMBH (DE) 2014-03-25 US disclosed
US-20120071461-A1 Substituted Benzamide Compounds GRUENENTHAL GMBH (DE) 2012-03-22 US disclosed
US-20120071461-A1 Substituted Benzamide Compounds GRUENENTHAL GMBH (DE) 2012-03-22 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120071461-A1 Substituted Benzamide Compounds BDKRB1, BDKRB2, HRH2 KMT2A 2222/4885MEN1 2563/4885MAPT 3149/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.